⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Allison DipasqualeM.D.

Surgical Oncology · Dallas, TX 75230

NPI: 1003045386

Share:

6

🟢 Low

Risk Flags

Very low drug diversity

Risk indicators are statistical patterns, not allegations. Learn more

168

Total Claims

$2,110

Drug Cost

79

Beneficiaries

$27

Cost/Patient

Risk Score Breakdown 6/100

Low (0)Moderate (15)Elevated (30)High (50+)
Low drug diversity+6

Score components are additive. Read full methodology

Peer Comparison vs. 526 Surgical Oncology providers

+3%

Opioid rate vs peers

29.8% vs 28.9% avg

-96%

Cost per patient vs peers

$27 vs $690 avg

🔎 Data Overview

🔍

Prescribes only 4 unique drugs with a 29.8% opioid rate. Very low drug diversity combined with high opioid prescribing is a classic statistical marker of potential pill mill operations. However, some legitimate practices (e.g., addiction treatment with buprenorphine) can show similar patterns.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

29.8%

Opioid Rate

50

Opioid Claims

$303

Opioid Cost

Long-Acting Rate

This provider's opioid prescribing rate of 29.8% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 167 claims · $2,099

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Anastrozole52$1,021
Acetaminophen With Codeine43$265
Cephalexin21$227
Sulfamethoxazole/Trimethoprim15$122

Prescribing Profile

4

Unique Drugs

6.0

Anomaly Score

Patient Profile

73

Avg Age

100%

Female

1.21

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About